ReviewFish physiology and biochemistry2026
Myostatin in fish: current understanding of its characterization, function, and signaling pathways.
Review in Fish physiology and biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myostatin (Mstn), a secretory protein from the transforming growth factor-β (TGF-β) superfamily, is mostly present in skeletal muscle across vertebrates. The mstn gene exhibits a conserved genomic structure consisting of three exons and two introns in both teleost fish and mammals. Unlike mammals which typically possess a single mstn copy, most fish species harbor two or more copies derived from whole-genome duplication events, and these paralogs show broader tissue expression profiles including muscle, brain, liver, kidney, and gonads. The function and mechanism of action in fish appear generally similar to those of other animals, although fish-specific gene duplication and tissue distribution patterns suggest possible functional divergence. Mstn primarily exerts its growth-inhibitory effect by suppressing muscle satellite cell activation, inhibiting myoblast proliferation, and downregulating myogenic regulatory factor (MRF) family expression. These molecular actions collectively restrict both hyperplastic and hypertrophic muscle growth. Disruptive mutations, including nucleotide deletions or substitutions, in the coding sequence of the fish mstn gene lead to a loss of Mstn function, which in turn stimulates myoblast proliferation and differentiation, potentially leading to pronounced muscle hyperplasia and hypertrophy. Emerging evidence further indicates that fish Mstn also plays pleiotropic roles in lipid metabolism regulation and immune modulation. In this paper, we evaluate the sequence structure, tissue distribution, function, and mechanism of mstn action in fish, with a focus on mstn's role and molecular mechanism in controlling fish muscle growth, to provide fundamental information for fish quality improvement.
Indexed as
Identifiers
42663749What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.